The fundamental role of epigenetics in hematopoietic malignanciesGALM, Oliver; HERMAN, James G; BAYLIN, Stephen B et al.Blood reviews. 2006, Vol 20, Num 1, pp 1-13, issn 0268-960X, 13 p.Article

Gene silencing in cancer in association with promoter hypermethylationHERMAN, James G; BAYLIN, Stephen B.The New England journal of medicine. 2003, Vol 349, Num 21, pp 2042-2054, issn 0028-4793, 13 p.Article

Stress and the epigenetic landscape: a link to the pathobiology of human diseases?JOHNSTONE, Sarah E; BAYLIN, Stephen B.Nature reviews. Genetics (Print). 2010, Vol 11, Num 11, pp 806-812, issn 1471-0056, 7 p.Article

DNA methylation and complete transcriptional silencing of cancer genes persist after depletion of EZH2MCGARVEY, Kelly M; GREENE, Eriko; FAHRNER, Jill A et al.Cancer research (Baltimore). 2007, Vol 67, Num 11, pp 5097-5102, issn 0008-5472, 6 p.Article

CpG island methylator phenotypes in aging and cancerTOYOTA, M; ISSA, J.-P. J.Seminars in cancer biology. 1999, Vol 9, Num 5, pp 349-357, issn 1044-579XArticle

Epigenetic BiomarkersCHAN, Timothy A; BAYLIN, Stephen B.Current Topics in Microbiology and Immunology. 2012, Vol 355, pp 189-216, issn 0070-217X, 28 p.Article

A gene hypermethylation profile of human cancerESTELLER, Manel; CORN, Paul G; BAYLIN, Stephen B et al.Cancer research (Baltimore). 2001, Vol 61, Num 8, pp 3225-3229, issn 0008-5472Article

hTERT is expressed in cancer cell lines despite promoter DNA methylation by preservation of unmethylated DNA and active chromatin around the transcription start siteZINN, Rebekah L; PRUITT, Kevin; EGUCHI, Sayaka et al.Cancer research (Baltimore). 2007, Vol 67, Num 1, pp 194-201, issn 0008-5472, 8 p.Article

Dependence of histone modifications and gene expression on DNA hypermethylation in cancerFAHRNER, Jill A; EGUCHI, Sayaka; HERMAN, James G et al.Cancer research (Baltimore). 2002, Vol 62, Num 24, pp 7213-7218, issn 0008-5472, 6 p.Article

Relationships between chromatin organization and DNA methylation in determining gene expressionJONES, P. L; WOLFFE, A. P.Seminars in cancer biology. 1999, Vol 9, Num 5, pp 339-347, issn 1044-579XArticle

Genomic and Epigenomic Integration Identifies a Prognostic Signature in Colon CancerJOO MI YI; DHIR, Mashaal; SMITS, Kim M et al.Clinical cancer research (Print). 2011, Vol 17, Num 6, pp 1535-1545, issn 1078-0432, 11 p.Article

Aberrant Silencing of Cancer-Related Genes by CpG Hypermethylation Occurs Independently of Their Spatial Organization in the NucleusEASWARAN, Hariharan P; VAN NESTE, Leander; COPE, Leslie et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 20, pp 8015-8024, issn 0008-5472, 10 p.Article

Can we improve the cytologic examination of malignant pleural effusions using molecular analysis?BROCK, Malcolm V; HOOKER, Craig M; BAYLIN, Stephen B et al.The Annals of thoracic surgery. 2005, Vol 80, Num 4, pp 1241-1247, issn 0003-4975, 7 p.Article

Promoter hypermethylation of the DNA repair gene O⁶-Methylguanine-DNA Methyltransferase is associated with the presence of G:C to A:T transition mutations in p53 in human colorectal tumorigenesisESTELLER, Manel; RISQUES, Rosa-Ana; TOYOTA, Minoru et al.Cancer research (Baltimore). 2001, Vol 61, Num 12, pp 4689-4692, issn 0008-5472Article

Novel Methylation Biomarker Panel for the Early Detection of Pancreatic CancerJOO MI YI; GUZZETTA, Angela A; PAPPOU, Emmanouil P et al.Clinical cancer research (Print). 2013, Vol 19, Num 23, pp 6544-6555, issn 1078-0432, 12 p.Article

CpG Island Methylator Phenotype―Positive Tumors in the Absence of MLH1 Methylation Constitute a Distinct Subset of Duodenal Adenocarcinomas and Are Associated with Poor PrognosisTAO FU; PAPPOU, Emmanouil P; WOLFGANG, Christopher L et al.Clinical cancer research (Print). 2012, Vol 18, Num 17, pp 4743-4752, issn 1078-0432, 10 p.Article

Silenced tumor suppressor genes reactivated by DNA demethylation do not return to a fully euchromatic chromatin stateMCGARVEY, Kelly M; FAHRNER, Jill A; GREENE, Eriko et al.Cancer research (Baltimore). 2006, Vol 66, Num 7, pp 3541-3549, issn 0008-5472, 9 p.Article

Hypermethylation of a small cpguanine-rich region correlates with loss of activator protein-2α expression during progression of breast cancerDOUGLAS, Donna B; AKIYAMA, Yoshimitsu; CARRAWAY, Hetty et al.Cancer research (Baltimore). 2004, Vol 64, Num 5, pp 1611-1620, issn 0008-5472, 10 p.Article

Promoter hypermethylation of resected bronchial margins: A field defect of changes?MINGZHOU GUO; HOUSE, Michael G; HOOKER, Craig et al.Clinical cancer research. 2004, Vol 10, Num 15, pp 5131-5136, issn 1078-0432, 6 p.Article

p14^ARF silencing by promoter hypermethylation mediates abnormal intracellular localization of MDM2ESTELLER, Manel; CORDON-CARDO, Carlos; BAYLIN, Stephen B et al.Cancer research (Baltimore). 2001, Vol 61, Num 7, pp 2816-2821, issn 0008-5472Article

Cancer-Related Epigenome Changes Associated with Reprogramming to Induced Pluripotent Stem CellsOHM, Joyce E; MALI, Prashant; WAYNE YU et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 19, pp 7662-7673, issn 0008-5472, 12 p.Article

Methylation of TFPI2 in Stool DNA: A Potential Novel Biomarker for the Detection of Colorectal CancerGLÖCKNER, Sabine C; DHIR, Mashaal; KHALID-DE BAKKER, Carolina A. J et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 11, pp 4691-4699, issn 0008-5472, 9 p.Article

Abnormal DNA Methylation of CD133 in Colorectal and Glioblastoma TumorsJOO MI YI; TSAI, Hsing-Chen; LATERRA, John et al.Cancer research (Chicago, Ill.). 2008, Vol 68, Num 19, pp 8094-8103, issn 0008-5472, 10 p.Article

A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencingOHM, Joyce E; MCGARVEYL, Kelly M; BERMAN, David M et al.Nature genetics. 2007, Vol 39, Num 2, pp 237-242, issn 1061-4036, 6 p.Article

Deletions of chromosome 8p and loss of sFRP1 expression are progression markers of papillary bladder cancerSTOEHR, Robert; WISSMANN, Christoph; SIMON, Ronald et al.Laboratory investigation. 2004, Vol 84, Num 4, pp 465-478, issn 0023-6837, 14 p.Article